| 000 | 05509naaaa2201453uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/76343 | ||
| 005 | 20220219213457.0 | ||
| 020 | _abooks978-3-0365-0445-2 | ||
| 020 | _a9783036504445 | ||
| 020 | _a9783036504452 | ||
| 024 | 7 |
_a10.3390/books978-3-0365-0445-2 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 072 | 7 |
_aH _2bicssc |
|
| 072 | 7 |
_aJFFP _2bicssc |
|
| 100 | 1 |
_aScotto D'Abusco, Anna _4edt |
|
| 700 | 1 |
_aScotto D'Abusco, Anna _4oth |
|
| 245 | 1 | 0 | _aNutraceuticals and Human Health |
| 260 |
_aBasel, Switzerland _bMDPI - Multidisciplinary Digital Publishing Institute _c2021 |
||
| 300 | _a1 electronic resource (340 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aIn this Special Issue, we have published papers on the health-promoting effects of nutraceuticals from different sources, and their effects in different pathologies. Extracts from plants have been analyzed, for example, extracts from olive leaves, Mikania micrantha, the devil’s claw, raspberries and others, alongside marine phytoplankton, egg-yolk and marketed dietary supplements. The effects of these extracts and dietary supplements have been studied in diseases associated with obesity, and in diseases where inflammation pathways are involved. The effectiveness of resveratrol and curcumin to support the anticancer activity of cisplatin has also been reported, as well as the ability of devil’s claw root extract to stimulate the CB2 receptors in synoviocytes in osteoarthritis patients. The anti-oxidant effect of marine phytoplankton has been studied on muscle damage, both in humans and in an animal model, and the effects of the metabolite of antocianin were analyzed in a mouse model of amyotrophic lateral sclerosis. Finally, reviews on the use of lactoferrin, ω3 and ω6 and abscisic acid have been reported, in addition to the crosstalk between prostate cancer and microbiota inflammation. Although it is not yet possible to draw definitive conclusions on the use of nutraceuticals, several mechanisms of action for many of them have been further clarified. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by/4.0/ _2cc _4https://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aEnglish | ||
| 650 | 7 |
_aHumanities _2bicssc |
|
| 650 | 7 |
_aSocial interaction _2bicssc |
|
| 653 | _afertility | ||
| 653 | _aingredients | ||
| 653 | _amale reproduction | ||
| 653 | _asemen parameters | ||
| 653 | _asupplements | ||
| 653 | _aallithiamine | ||
| 653 | _agarlic | ||
| 653 | _ahyperglycaemia | ||
| 653 | _aadvanced glycation end-products | ||
| 653 | _acytokines | ||
| 653 | _aabscisic acid | ||
| 653 | _aprediabetes | ||
| 653 | _atype 2 diabetes mellitus | ||
| 653 | _ametabolic syndrome | ||
| 653 | _ainsulin resistance | ||
| 653 | _aadipocyte browning | ||
| 653 | _aAMP-activated protein kinase | ||
| 653 | _afood supplement | ||
| 653 | _aframbinone | ||
| 653 | _ameal frequency | ||
| 653 | _aopen-field test | ||
| 653 | _aelevated plus maze | ||
| 653 | _asensory motor gating | ||
| 653 | _apre-pulse inhibition | ||
| 653 | _ac-Fos | ||
| 653 | _aamyotrophic lateral sclerosis | ||
| 653 | _aanti-inflammatory | ||
| 653 | _aantioxidant | ||
| 653 | _aphenolic acid | ||
| 653 | _aneuroprotective | ||
| 653 | _aneurodegeneration | ||
| 653 | _aobesity | ||
| 653 | _aoverweight | ||
| 653 | _abeta-glucans | ||
| 653 | _achitosan | ||
| 653 | _afollow up study | ||
| 653 | _aweight loss programs | ||
| 653 | _aweight gain | ||
| 653 | _aweight loss | ||
| 653 | _abody weight changes | ||
| 653 | _aphytoplankton | ||
| 653 | _aantioxidants | ||
| 653 | _amuscle damage | ||
| 653 | _amuscle recovery | ||
| 653 | _amuscle soreness | ||
| 653 | _aViburnum opulus | ||
| 653 | _aphenolic compounds | ||
| 653 | _aadipogenesis | ||
| 653 | _aPPARγ | ||
| 653 | _alipase inhibition | ||
| 653 | _agreen tea | ||
| 653 | _aepigallocatechin | ||
| 653 | _alipid profile | ||
| 653 | _ahigh-fat diet | ||
| 653 | _afast food | ||
| 653 | _aosteoarthritis | ||
| 653 | _anutraceuticals | ||
| 653 | _apolyphenols | ||
| 653 | _avolatile compounds | ||
| 653 | _aβ-caryophyllene | ||
| 653 | _aeugenol | ||
| 653 | _aFAAH | ||
| 653 | _acannabinoid receptors | ||
| 653 | _aphospholipases | ||
| 653 | _alactoferrin | ||
| 653 | _abovine milk | ||
| 653 | _anutraceutical | ||
| 653 | _ahuman health | ||
| 653 | _aresveratrol | ||
| 653 | _acurcumin | ||
| 653 | _acisplatin | ||
| 653 | _ahead and neck cancer | ||
| 653 | _acell cycle | ||
| 653 | _aapoptosis | ||
| 653 | _aprostate cancer | ||
| 653 | _amicrobiota | ||
| 653 | _anutraceutical compounds | ||
| 653 | _afecundation | ||
| 653 | _ainflammation | ||
| 653 | _acytokine | ||
| 653 | _agrowth factors | ||
| 653 | _ametabolomics | ||
| 653 | _alipidomics | ||
| 653 | _aω-3PUFAs | ||
| 653 | _aω-6PUFAs | ||
| 653 | _aendocannabinoids | ||
| 653 | _aCRC | ||
| 653 | _afatty acids | ||
| 653 | _aGymnema inodorum | ||
| 653 | _agymnemic acid | ||
| 653 | _aMikania micrantha | ||
| 653 | _aanti-hypercholesterolemia | ||
| 653 | _asteatosis | ||
| 653 | _aolive leaf | ||
| 653 | _amacrophages | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/3765 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/76343 _70 _zDOAB: description of the publication |
| 999 |
_c45241 _d45241 |
||